Literature DB >> 31482181

Rapid progression of skin sclerosis precipitated by a pheochromocytoma in a patient with systemic sclerosis.

Jongtaek Lee1, Yunsuek Kim1, Yoonmi Jin2, Hyun-Sook Kim1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31482181      PMCID: PMC6717778          DOI: 10.11622/smedj.2019091

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


× No keyword cloud information.
  7 in total

1.  Early presentation of phaeochromocytoma as acute arterial disease.

Authors:  D D Muehrcke; B P Bliss
Journal:  Br J Hosp Med       Date:  1988-06

Review 2.  Pheochromocytoma: an approach to antihypertensive management.

Authors:  Emmanuel L Bravo
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

3.  Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study.

Authors:  A B Olesen; C Svaerke; D K Farkas; H T Sørensen
Journal:  Br J Dermatol       Date:  2010-10       Impact factor: 9.302

4.  Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.

Authors:  Ami A Shah; Laura K Hummers; Livia Casciola-Rosen; Kala Visvanathan; Antony Rosen; Fredrick M Wigley
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

5.  Skin blood flow and plasma catecholamine concentrations during removal of a phaeochromocytoma in a child.

Authors:  H Mikasa; T Sakuragi; K Higa; M Yasumoto
Journal:  Br J Anaesth       Date:  2004-03-05       Impact factor: 9.166

6.  Toe necrosis and acute myocardial infarction precipitated by a pheochromocytoma in a patient with systemic sclerosis.

Authors:  Alexandra Balbir-Gurman; Abraham Menahem Nahir; Alexander Rozin; Doron Markovits; Yolanda Braun-Moscovici
Journal:  J Clin Rheumatol       Date:  2007-12       Impact factor: 3.517

7.  Phaeochromocytoma mimicking scleroderma.

Authors:  Joan Joo-Ching Khoo; Edward John Pratt
Journal:  Int J Endocrinol       Date:  2011-02-23       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.